Q4 2025 Earnings Conference Call Announcement
-
SK Bioscience to hold face-to-face IR on Feb 5-6, 2026 -
Target: domestic institutional investors; Host: NH Investment & Securities -
Purpose: Q4 2025 earnings and business update -
IR materials to be posted on website on Feb 3 -
Schedule subject to change
KOSPI Filing Information
- Filing: Corporate Briefing (IR) Holding (Notice Disclosure)
- Company: SK Bioscience (302440)
- Submission: SK Bioscience Co.,Ltd
- Receipt: 02-03-2026
- Under KRX KOSPI Market Division